- Home
- BBIO vs DDS Comparison
BBIO vs DDS Comparison
Compare BBIO & DDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- DDS
- Stock Information
- Founded
- BBIO 2015
- DDS 1938
- Country
- BBIO United States
- DDS United States
- Employees
- BBIO N/A
- DDS N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- DDS Department/Specialty Retail Stores
- Sector
- BBIO Health Care
- DDS Consumer Discretionary
- Exchange
- BBIO Nasdaq
- DDS Nasdaq
- Market Cap
- BBIO 8.8B
- DDS 7.3B
- IPO Year
- BBIO 2019
- DDS N/A
- Fundamental
- Price
- BBIO $49.08
- DDS $532.60
- Analyst Decision
- BBIO Strong Buy
- DDS Sell
- Analyst Count
- BBIO 16
- DDS 3
- Target Price
- BBIO $61.69
- DDS $394.33
- AVG Volume (30 Days)
- BBIO 2.9M
- DDS 133.1K
- Earning Date
- BBIO 08-05-2025
- DDS 08-14-2025
- Dividend Yield
- BBIO N/A
- DDS 5.13%
- EPS Growth
- BBIO N/A
- DDS N/A
- EPS
- BBIO N/A
- DDS 36.27
- Revenue
- BBIO $235,812,000.00
- DDS $6,585,731,000.00
- Revenue This Year
- BBIO $106.33
- DDS N/A
- Revenue Next Year
- BBIO $54.30
- DDS N/A
- P/E Ratio
- BBIO N/A
- DDS $14.71
- Revenue Growth
- BBIO 7.62
- DDS N/A
- 52 Week Low
- BBIO $21.72
- DDS $282.24
- 52 Week High
- BBIO $51.86
- DDS $535.01
- Technical
- Relative Strength Index (RSI)
- BBIO 55.76
- DDS 68.00
- Support Level
- BBIO $48.03
- DDS $495.00
- Resistance Level
- BBIO $51.86
- DDS $528.00
- Average True Range (ATR)
- BBIO 1.95
- DDS 20.56
- MACD
- BBIO -0.08
- DDS 2.38
- Stochastic Oscillator
- BBIO 71.55
- DDS 97.10
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About DDS Dillard's Inc.
Dillard's Inc is an American fashion apparel, cosmetics, and home furnishings retailer. Its stores offer a large variety of merchandise and feature products from both national and exclusive brand sources. The company also operates a general contracting construction company, CDI Contractors. CDI Contractors' business includes constructing and remodelling stores for Dillards. The merchandise selections include exclusive brand merchandise such as Antonio Melani, Gianni Bini, Daniel Cremieux, Roundtree & Yorke, and private-label merchandise, among others. The company operates in two business segments; Retail Operations and Construction. The Retail Operations segment generates maximum revenue for the company.